{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:37:31Z","timestamp":1760852251286,"version":"3.32.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.pnpbp.2006.05.007","type":"journal-article","created":{"date-parts":[[2006,7,8]],"date-time":"2006-07-08T11:20:01Z","timestamp":1152357601000},"page":"1304-1312","source":"Crossref","is-referenced-by-count":15,"title":["Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5\u2032-O-(\u03b3-thiotriphosphate) binding in rat striatal membranes"],"prefix":"10.1016","volume":"30","author":[{"given":"Yuji","family":"Odagaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.05.007_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0924-977X(95)00022-H","article-title":"Dopamine agonists in schizophrenia: a review","author":"Benkert","year":"1995","journal-title":"Eur Neuropsychopharmacol Suppl"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1471-4159.1993.tb05863.x","article-title":"Differences in the ligand binding properties of the short and long versions of the D2 dopamine receptor","volume":"60","author":"Castro","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.pa.33.040193.001433","article-title":"Molecular diversity of the dopamine receptors","volume":"32","author":"Civelli","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib4","first-page":"393","article-title":"Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia","volume":"25","author":"Coward","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2003.11.077","article-title":"Characterization of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapine","volume":"485","author":"Cussac","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","article-title":"Dopamine, depression and antidepressants","volume":"18","author":"Dailly","year":"2004","journal-title":"Fund Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00702-003-0059-x","article-title":"Dopamine receptor agonists in the therapy of Parkinson's disease","volume":"111","author":"Foley","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-003-0027-5","article-title":"Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum","volume":"110","author":"Gerlach","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib9","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0024-3205(99)00412-9","article-title":"Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTP\u03b3S binding","volume":"65","author":"Geurts","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/BF01271201","article-title":"Antipsychotics with inverse agonist activity at the dopamine D3 receptor","volume":"103","author":"Griffon","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.bjp.0701196","article-title":"Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors","volume":"121","author":"Hall","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0006-2952(84)90441-6","article-title":"Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes","volume":"33","author":"Hamblin","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.lfs.2003.07.005","article-title":"The [35S]GTP\u03b3S binding assay: approaches and applications in pharmacology","volume":"74","author":"Harrison","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-2999(86)90389-4","article-title":"Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum","volume":"121","author":"Hess","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-8993(87)90040-0","article-title":"The characterization of [3H]sulpiride binding sites in rat striatal membranes","volume":"402","author":"Imafuku","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib16","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0028-3908(96)00100-1","article-title":"Dopamine receptors and brain function","volume":"35","author":"Jaber","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib17","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.mp.4001093","article-title":"NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors\u2014implications for models of schizophrenia","volume":"7","author":"Kapur","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1359-6446(97)01075-1","article-title":"Compounds selective for dopamine receptor subtypes","volume":"2","author":"Kebabian","year":"1997","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-6147(93)90018-F","article-title":"Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation","volume":"14","author":"Lazareno","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lfs.2003.09.028","article-title":"Homo- and hetero-oligomerization of G protein-coupled receptors","volume":"74","author":"Lee","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib22","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.89.17.8155","article-title":"Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin","volume":"89","author":"L\u00e9vesque","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib23","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.90.19.8861","article-title":"Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies","volume":"90","author":"Levey","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0922-4106(95)90013-6","article-title":"Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors","volume":"290","author":"Mierau","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.104.000497.","article-title":"G protein-coupled receptor dimerization: function and ligand pharmacology","volume":"66","author":"Milligan","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib26","series-title":"The dopamine receptors","first-page":"27","article-title":"Molecular biology of dopamine receptors","author":"Neve","year":"1997"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1081\/RRS-200029981","article-title":"Dopamine receptor signaling","volume":"24","author":"Neve","year":"2004","journal-title":"J Recept Signal Trans"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-8993(01)02927-4","article-title":"Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra","volume":"920","author":"Newman-Tancredi","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.102.039875","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptors. II. Agonist and antagonist properties at subtypes of dopamine D2-like receptor and \u03b11\/\u03b12-adrenoceptor","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl 5","key":"10.1016\/j.pnpbp.2006.05.007_bib30","first-page":"60","article-title":"Dopaminergic agents and stimulants as antidepressant augmentation strategies","volume":"59","author":"Nierenberg","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-2952(95)00146-Q","article-title":"Functional coupling of dopamine D2 and muscarinic cholinergic receptors to their respective G proteins assessed by agonist-induced activation of high-affinity GTPase activity in rat striatal membranes","volume":"50","author":"Odagaki","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1254\/jphs.FPJ05010X","article-title":"Detailed pharmacological characterization of 5-HT1A-receptor-mediated [35S]GTP\u03b3S binding in rat hippocampal membranes","volume":"98","author":"Odagaki","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2005.07.018","article-title":"5-HT1A receptor-mediated G protein activation assessed by [35S]GTP\u03b3S binding in rat cerebral cortex","volume":"521","author":"Odagaki","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00210-006-0041-x","article-title":"5-HT-stimulated [35S]guanosine-5\u2032-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes","volume":"372","author":"Odagaki","year":"2006","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1742-7843.2004.pto940206.x","article-title":"\u03b3-Hydroxybutyric acid, unlike \u03b3-aminobutyric acid, does not stimulate Gi\/Go proteins in rat brain membranes","volume":"94","author":"Odagaki","year":"2004","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib36","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00702-004-0237-5","article-title":"Lack of G protein-coupled sigma receptors in rat brain membranes: receptor-mediated high-affinity GTPase activity and [35S]GTP\u03b3S binding studies","volume":"112","author":"Odagaki","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib37","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1016\/0006-2952(87)90274-7","article-title":"Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum","volume":"36","author":"Onali","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-2999(96)00695-4","article-title":"Pharmacology of U-91356A, an agonist for the dopamine D2 receptor subtype","volume":"317","author":"Piercey","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib39","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-3565(24)36885-5","article-title":"II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1","volume":"282","author":"Primus","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib40","first-page":"1355","article-title":"Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907","volume":"275","author":"Pugsley","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0006-2952(98)00287-1","article-title":"Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5-(\u03b3-thiotriphosphate) ([35S]GTP\u03b3S) binding in rat striatal membranes","volume":"57","author":"Rinken","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib42","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1124\/mol.104.004077","article-title":"Mechanisms of agonist action at D2 dopamine receptors","volume":"66","author":"Roberts","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib46","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1471-4159.1985.tb07233.x","article-title":"Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor","volume":"45","author":"Schulz","year":"1985","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib43","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1096\/fasebj.4.10.2197154","article-title":"Dopamine receptors and transporters in Parkinson's disease and schizophrenia","volume":"4","author":"Seeman","year":"1990","journal-title":"FASEB J"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","article-title":"Dopamine receptor pharmacology","volume":"15","author":"Seeman","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib45","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1016\/S0021-9258(20)65148-1","article-title":"Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor","volume":"257","author":"Sibley","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0922-4106(92)90107-7","article-title":"Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor","volume":"225","author":"Sokoloff","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s007020200033","article-title":"Partial dopamine agonists in the treatment of psychosis","volume":"109","author":"Tamminga","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2006.05.007_bib49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004850-199711000-00002","article-title":"The dopamine hypothesis of schizophrenia: current status, future prospects","volume":"12","author":"Willner","year":"1997","journal-title":"Int Clin Psychopharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606002181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606002181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T21:05:36Z","timestamp":1736456736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606002181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0278584606002181"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.05.007","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}